Inceptionr LLC Sells 1,515 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Inceptionr LLC lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 38.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,395 shares of the company’s stock after selling 1,515 shares during the period. Inceptionr LLC’s holdings in HCA Healthcare were worth $719,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of HCA. Whipplewood Advisors LLC bought a new stake in shares of HCA Healthcare in the 4th quarter valued at about $31,000. Legacy Investment Solutions LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $39,000. Activest Wealth Management lifted its stake in shares of HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after acquiring an additional 125 shares during the last quarter. Capital Performance Advisors LLP purchased a new position in HCA Healthcare during the 3rd quarter valued at about $41,000. Finally, Pinnacle Bancorp Inc. increased its holdings in HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after purchasing an additional 50 shares during the period. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

HCA stock opened at $330.11 on Friday. The stock has a market capitalization of $81.98 billion, a PE ratio of 15.03, a price-to-earnings-growth ratio of 1.10 and a beta of 1.64. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The stock’s 50 day simple moving average is $316.70 and its 200 day simple moving average is $347.69.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the firm posted $5.90 EPS. As a group, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 13.11%.

Analyst Ratings Changes

HCA has been the topic of a number of research analyst reports. Cantor Fitzgerald restated an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. Morgan Stanley reduced their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. Barclays reduced their target price on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. KeyCorp reduced their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Finally, Royal Bank of Canada reduced their target price on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $385.67.

Insider Activity

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.